Clinical Trial Update: Study and Treatment of Post Lyme Disease (STOP-LD) [Phase 3]

View source ↗

Summary

The STOP-LD Phase 3 trial investigating antibiotic treatment for post-Lyme disease syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Lyme Disease | Phase 3 | Status: COMPLETED